Changes Feb. 18, 2019
The following is a list of changes on monitored regulatory lists which occurred between Feb. 18, 2019 and Feb. 18, 2019.
Legend
- regulatory records added to the list
- regulatory records removed from the list
- changed regulatory records
For changed records, you can see the history of changes by following the link to the corresponding regulatory record.
Biocidal active substances
- 1-[[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-yl]methyl]-1H-1,2,4-triazole (Propiconazole)
- 3-iodo-2-propynylbutylcarbamate (IPBC)
- Brodifacoum
- N,N-diethyl-meta-toluamide
- tebuconazole
Candidate List of SVHCs for Authorisation
- 5-sec-butyl-2-(2,4-dimethylcyclohex-3-en-1-yl)-5-methyl-1,3-dioxane
- 5-sec-butyl-2-(2,4-dimethylcyclohex-3-en-1-yl)-5-methyl-1,3-dioxane [1], 5-sec-butyl-2-(4,6-dimethylcyclohex-3-en-1-yl)-5-methyl-1,3-dioxane [2]
- 5-sec-butyl-2-(4,6-dimethylcyclohex-3-en-1-yl)-5-methyl-1,3-dioxane
Registry of CLH intentions until outcome
- (2RS)-2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1H-1,2,4-triazol-1-yl)propan-2-ol; mefentrifluconazole
- (3aS,5S,6R,7aR,7bS,9aS,10R,12aS,12bS)-10-[(2S,3R,4R,5R)-3,4-dihydroxy-5,6-dimethylheptan-2-yl]-5,6-dihydroxy-7a,9a-dimethylhexadecahydro-3H-benzo[c]indeno[5,4-e]oxepin-3-one; 24-epibrassinolide
- (RS)-1-{1-ethyl-4-[4-mesyl-3-(2-methoxyethoxy)-o-toluoyl]pyrazol-5-yloxy}ethyl methyl carbonate; tolpyralate
- (RS)-2-methoxy-N-methyl-2-[α-(2,5-xylyloxy)-o-tolyl]acetamide
- (RS)-3-Allyl-2-methyl-4-oxocyclopent-2- enyl-(1R,3R;1R,3S)-2,2-dimethyl-3-(2- methylprop-1-enyl)-cyclopropanecarboxy late (mixture of 4 isomers 1R trans, 1R:1R trans, 1S: 1R cis, 1R: 1R cis,1S 4:4:1:1) (d-Allethrin)
- 1,4-dimethylnaphthalene
- 1-[(Z)-[2-(4-cyanophenyl)-1-[3-(trifluoromethyl)phenyl]ethylidene]amino]-1-[4-(trifluoromethoxy)phenyl]urea
- 1-[2-({[1-(4-chlorophenyl)-1H-pyrazol-3-yl]oxy}methyl)-3-methylphenyl]-4-methyl-1,4-dihydro-5H-tetrazol-5-one; metyltetraprole
- 1-[[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-yl]methyl]-1H-1,2,4-triazole
- 2,2-dibromo-2-cyanoacetamide
- 2,4,6,8-tetramethyl-1,3,5,7-tetraoxacyclooctane
- 2,4-dinitrophenol
- 2-(2-butoxyethoxy)ethyl 6-propylpiperonyl ether
- 2-(4-tert-butylbenzyl)propionaldehyde
- 2-amino-3-chloro-1,4-naphthoquinone
- 2-bromo-2-(bromomethyl)pentanedinitrile
- 2-ethylhexyl 10-ethyl-4,4-dioctyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate
- 2-phenoxyethanol
- 3-decen-2-one
- 3-hydroxy-5-methylisoxazole
- 4,5-dichloro-2-octyl-2H-isothiazol-3-one
- 4-{[(6-chloropyridin-3-yl)methyl](2,2-difluoroethyl)amino}-2,5-dihydrofuran-2-one
- Benfluralin
- Bentazone
- Bis(1-hydroxy-1H-pyridine-2-thionato-O,S)copper
- Carbendazim
- Chlorpropham
- Cinnamaldehyde
- Citric acid
- Confidential or not yet assessed substance
- Daminozide
- Dazomet
- Desmedipham
- Dimethyl disulphide
- Ethofumesate
- Formic acid
- Glyphosate
- L-(+)-lactic acid
- Lavender, Lavandula hybrida, ext.
- Lead
- MBIT
- Margosa, ext.
- Mecetronium etilsulfate
- N-(2-{[1,1'-bi(cyclopropane)]-2-yl}phenyl)-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide
- N-Didecyl-N-dipolyethoxyammonium borate/Didecylpolyoxethylammonium borate (Polymeric betaine)
- N-cyclopropyl-1,3,5-triazine-2,4,6-triamine
- N-{5,7-dimethoxy-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl}-2-methoxy-4-(trifluoromethyl)pyridine-3-sulfonamide
- O-(6-chloro-3-phenylpyridazin-4-yl) S-octyl thiocarbonate
- Oil of lemon eucalyptus
- Ozone
- PHMB
- PHMB
- Phenmedipham
- Pirimiphos-methyl
- Polyhexamethylene biguanide hydrochloride
- Propyl [3-(dimethylamino)propyl]carbamate monohydrochloride
- Pyridazine-3,6-diol
- Pyrithione zinc
- Reaction mass of 3-(difluoromethyl)-1-methyl-N-[(1RS,4SR,9RS)-1,2,3,4-tetrahydro-9-isopropyl-1,4-methanonaphthalen-5-yl]pyrazole-4-carboxamide and of 3-(difluoromethyl)-1-methyl-N-[(1RS,4SR,9SR)-1,2,3,4-tetrahydro-9-isopropyl-1,4-methanonaphthalen-5-yl]pyrazole-4-carboxamide; isopyrazam
- Silanamine, 1,1,1-trimethyl-N-(trimethylsilyl)-, hydrolysis products with silica
- Silver copper zeolite
- Silver sodium zirconium hydrogenphosphate
- Silver zeolite (Zeolite, LTA framework type, ion exchanged with silver and ammonium ions)
- Sodium N-(hydroxymethyl)glycinate
- Sodium hypochlorite
- Sulphur dioxide
- Thiabendazole
- Thiophanate-methyl
- [S-(Z,E)]-5-(1-hydroxy-2,6,6-trimethyl-4-oxocyclohex-2-en-1-yl)-3-methylpenta-2,4-dienoic acid
- acetamiprid (ISO); (1E)-N-[(6-chloropyridin-3-yl)methyl]-N'-cyano-N-methylethanimidamide; (E)-N1-[(6-chloro-3-pyridyl)methyl]-N2-cyano-N1-methylacetamidine
- and 2-methyl-2H -isothiazol-3-one [EC no. 220-239-6] (3:1)
- azamethiphos (ISO); S-[(6-chloro-2-oxooxazolo[4,5-b]pyridin-3(2H)-yl)methyl] O,O-dimethyl thiophosphate
- azoxystrobin (ISO); methyl (E)-2-{2-[6-(2-cyanophenoxy)pyrimidin-4-yloxy]phenyl}-3-methoxyacrylate
- benzyl 4-amino-3-chloro-6-(4-chloro-2-fluoro-3-methoxyphenyl)-5-fluoropyridine-2-carboxylate; florpyrauxifen-benzyl
- beta-cyfluthrin (ISO); reaction mass of rel-(R)-cyano(4-fluoro-3-phenoxyphenyl)methyl (1S,3S)-3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropane-1-carboxylate and rel-(R)-cyano(4-fluoro-3-phenoxyphenyl)methyl (1S,3R)-3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropane-1-carboxylate (ratio 1:2)
- carfentrazone-ethyl (ISO); ethyl (RS)-2-chloro-3-[2-chloro- 4-fluoro-5-[4-difluoromethyl-4,5-dihydro-3-methyl-5-oxo-1H-1,2,4-triazol-1-yl]phenyl]propionate
- chlorfenapyr (ISO); 4-bromo-2-(4-chlorophenyl)-1- ethoxymethyl-5-trifluoromethylpyrrole-3-carbonitrile
- clofentezine (ISO); 3,6-bis(o-chlorophenyl)-1,2,4,5-tetrazine
- clomazone (ISO); 2-(2-chlorobenzyl)-4,4-dimethyl-1,2-oxazolidin-3-one
- clothianidin (ISO); (E)-1-(2-chloro-1,3-thiazol-5-ylmethyl)-3-methyl-2-nitroguanidine
- copper; copper, granulated
- difenoconazole (ISO); 1-({2-[2-chloro-4-(4-chlorophenoxy)phenyl]-4-methyl-1,3-dioxolan-2-yl}methyl)-1H-1,2,4-triazole; 3-chloro-4-[(2RS,4RS;2RS,4SR)-4-methyl-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-2-yl]phenyl 4-chlorophenyl ether
- diflufenican (ISO); N-(2,4-difluorophenyl)-2-[3-(trifluoromethyl)phenoxy]-3-pyridinecarboxamide
- dimethomorph (ISO); 4-(3-(4-chlorophenyl)-3-(3,4-dimethoxyphenyl)acryloyl)morpholine
- dimoxystrobin (ISO); (2E)-2-{2-[(2,5-dimethylphenoxy)methyl]phenyl}-2-(methoxyimino)-N-methylacetamide; (E)-2-(methoxyimino)-N-methyl-2-[a-(2,5-xylyloxy)-o-tolyl]acetamide
- dinotefuran (ISO); 1-methyl-2-nitro-3-(tetrahydro-3-furylmethyl)guanidine
- emamectin benzoate (ISO); (4’’R)-4’’-deoxy-4’’-(methylamino)avermectin B1 benzoate
- empenthrin (ISO); 1-ethynyl-2-methylpent-2-enyl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate
- esfenvalerate (ISO); (αS)-α-cyano-3-phenoxybenzyl (2S)-2-(4-chlorophenyl)-3-methylbutyrate
- ethametsulfuron-methyl (ISO); methyl 2-[(4-ethoxy-6-methylamino-1,3,5-triazin-2-yl)carbamoylsulfamoyl]benzoate
- fenpropidin (ISO); (R,S)-1-[3-(4-tert-butylphenyl)-2-methylpropyl]piperidine
- fipronil (ISO); (±)-5-amino-1-(2,6-dichloro-α,α,α-trifluoro-para-tolyl)-4-trifluoromethylsulfinyl-pyrazole-3-carbonitrile